Amicus Therapeutics Inc (NASDAQ:FOLD)

16.48
Delayed Data
As of Jul 28
 +0.69 / +4.37%
Today’s Change
3.92
Today|||52-Week Range
17.42
+98.08%
Year-to-Date

Today’s Trading

Previous close15.79
Today’s open15.84
Day’s range-- - --
Volume1,322,414
Average volume (3 months)2,045,973
Market cap$1.8B
Dividend yield--
Data as of 07/28/2015

Growth & Valuation

Earnings growth (last year)+19.83%
Earnings growth (this year)-12.90%
Earnings growth (next 5 years)--
Revenue growth (last year)+237.19%
P/E ratioNM
Price/Sales506.03
Price/Book12.35

Competitors

 Today’s
change
Today’s
% change
THRXTheravance Inc+0.53+3.43%
PTCTPTC Therapeutics Inc+0.50+0.94%
TTPHTetraphase Pharmaceu...-0.37-0.76%
ADROAduro Biotech Inc+0.18+0.68%
Data as of 07/28/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$1.2M
Annual profit (last year)-$68.9M
Net profit margin-5,631.21%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John Francis Crowley
President &
Chief Operating Officer
Bradley L. Campbell
Corporate headquarters
Cranbury, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers